Pelthos Therapeutics PTHS Estimates

NYSE PTHS
$26.53 +0.69 (+2.67%)
At close: Aug 20, 2026 · 4:00 PM EDT

Detailed analyst consensus, revenue, and earnings forecasts vs reported data.

Quarterly Revenue Estimates

Metric Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27
Reported (Actual) 150,000.000.007.41 M9.39 M10.91 M----
High Estimate -0.004.53 M9.85 M11.76 M16.45 M19.24 M19.75 M27.91 M
Low Estimate -0.003.75 M9.11 M10.02 M15.48 M15.91 M17.77 M23.93 M
Consensus Estimate -0.004.14 M9.48 M10.89 M15.96 M17.57 M18.76 M25.92 M

Quarterly Earnings Per Share (EPS) Estimates

Metric Q1 24Q2 24Q3 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27
Reported (Actual) -5.50---3.21-5.38-5.30-6.87-3.09----
High Estimate --2.98-2.06-2.63-5.00-0.57-3.14-3.32-2.58-2.23-2.08-0.28
Low Estimate --3.48-2.26-2.91-5.90-0.63-3.84-3.90-2.74-2.39-2.34-0.32
Consensus Estimate --3.23-2.16-2.77-5.45-0.60-3.49-3.61-2.66-2.31-2.21-0.30